NorthWest Biotherapeutics Inc (NWBO)

[pgsd]

On page two of the article:-

https://xconomy.com/national/2019/01/16/merck-and-the-future-of-immuno-oncology-a-chat-with-roger-perlmutter/2/

as follows:-

RP: We’ve known Moderna since before they started. Shortly after I returned to Merck in 2013, they said they’d found something surprising—in principle they could make any vaccine component just from the mRNA. We have a very big vaccine business, and I’m interested in improving it. Maybe we could use this to get at some things that are otherwise extremely hard to engineer—a common flu vaccine, for example, so you don’t have to make a new one every year based on what shows up in Hong Kong. Or a vaccine for respiratory syncytial virus, for which we’ve never been able to develop a satisfactory immunization regimen.